Intercept Pharmaceuticals Inc. (ICPT)

81.96
NASDAQ : Health Technology
Prev Close 82.76
Day Low/High 81.94 / 83.70
52 Wk Low/High 56.76 / 131.87
Avg Volume 490.40K
Exchange NASDAQ
Shares Outstanding 32.73M
Market Cap 2.71B
EPS -10.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Intercept To Announce Third Quarter 2019 Financial Results On November 5, 2019

Intercept To Announce Third Quarter 2019 Financial Results On November 5, 2019

NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.

Intercept Announces New NASH And PBC Data To Be Presented At The Liver Meeting® 2019

Intercept Announces New NASH And PBC Data To Be Presented At The Liver Meeting® 2019

New analyses from Phase 3 REGENERATE study evaluating the effects of OCA on non-invasive liver fibrosis tests and NASH patient-reported outcomes Five-year analysis of long-term Ocaliva ® treatment in patients with PBC selected for inclusion in 'Best of...

Intercept Submits New Drug Application To The U.S. FDA For Obeticholic Acid In Patients With Fibrosis Due To NASH

Intercept Submits New Drug Application To The U.S. FDA For Obeticholic Acid In Patients With Fibrosis Due To NASH

NDA supported by positive interim analysis results from REGENERATE Phase 3 study demonstrating OCA's improvement of liver fibrosis without worsening of NASH

Intercept To Present At Upcoming Investor Conference In October

Intercept To Present At Upcoming Investor Conference In October

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.

Intercept Launches NASHTRUTH.com, An Online Educational Resource For People With Advanced Fibrosis Due To NASH

Intercept Launches NASHTRUTH.com, An Online Educational Resource For People With Advanced Fibrosis Due To NASH

New NASH survey available on NASHTRUTH.com reveals that 6 out of 10 NASH patients say there is not enough information about the disease available to them   NASHTRUTH.

Intercept Appoints Lisa DeFrancesco As Vice President, Investor Relations

Intercept Appoints Lisa DeFrancesco As Vice President, Investor Relations

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.

Intercept To Present At Upcoming Investor Conferences In September

Intercept To Present At Upcoming Investor Conferences In September

NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals Reports Second Quarter 2019 Financial Results And Provides Business Update

Intercept Pharmaceuticals Reports Second Quarter 2019 Financial Results And Provides Business Update

Company delivers strongest quarter to date with worldwide Ocaliva ® net sales of $65.

Intercept To Announce Second Quarter 2019 Financial Results On August 7, 2019

Intercept To Announce Second Quarter 2019 Financial Results On August 7, 2019

NEW YORK, July 31, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its...

Interesting ICPT Put And Call Options For September 6th

Interesting ICPT Put And Call Options For September 6th

Investors in Intercept Pharmaceuticals Inc saw new options become available today, for the September 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new September 6th contracts and identified one put and one call contract of particular interest.

First Week Of March 2020 Options Trading For Intercept Pharmaceuticals (ICPT)

First Week Of March 2020 Options Trading For Intercept Pharmaceuticals (ICPT)

Investors in Intercept Pharmaceuticals Inc saw new options become available this week, for the March 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

February 2020 Options Now Available For Intercept Pharmaceuticals (ICPT)

February 2020 Options Now Available For Intercept Pharmaceuticals (ICPT)

Investors in Intercept Pharmaceuticals Inc saw new options become available today, for the February 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 221 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Shares of Intercept Pharmaceuticals Rise Sharply on Drug Trial Results

Shares of Intercept Pharmaceuticals Rise Sharply on Drug Trial Results

Intercept Pharmaceuticals surges Tuesday after the release of positive test results for a new liver disease drug.

Noteworthy Friday Option Activity: ICPT, VICR, DVAX

Noteworthy Friday Option Activity: ICPT, VICR, DVAX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intercept Pharmaceuticals Inc , where a total of 2,370 contracts have traded so far, representing approximately 237,000 underlying shares. That amounts to about 46.9% of ICPT's average daily trading volume over the past month of 505,040 shares.

Notable Friday Option Activity: ICPT, AMRS, MDXG

Notable Friday Option Activity: ICPT, AMRS, MDXG

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intercept Pharmaceuticals Inc , where a total of 3,592 contracts have traded so far, representing approximately 359,200 underlying shares. That amounts to about 125.1% of ICPT's average daily trading volume over the past month of 287,220 shares.

The Best Thing PepsiCo Has Going for It Now

The Best Thing PepsiCo Has Going for It Now

The real reason the stock may be popping after the CEO news.

Interesting ICPT Put And Call Options For June 8th

Investors in Intercept Pharmaceuticals Inc saw new options begin trading today, for the June 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new June 8th contracts and identified one put and one call contract of particular interest.

First Week of ICPT May 18th Options Trading

First Week of ICPT May 18th Options Trading

Investors in Intercept Pharmaceuticals Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

Intercept Announces Multiple New Ocaliva® (obeticholic Acid) Data Presentations At The International Liver Congress™ 2018

Intercept Announces Multiple New Ocaliva® (obeticholic Acid) Data Presentations At The International Liver Congress™ 2018

Late-breaking presentation will feature the first clinical data from a biopsy-based substudy supporting obeticholic acid's ability to reverse or stabilize fibrosis and cirrhosis in primary biliary cholangitis (PBC) patients

TheStreet Quant Rating: D- (Sell)